Arbutus Biopharma Corp (ABUS)
3.51
+0.05
(+1.45%)
USD |
NASDAQ |
Nov 22, 16:00
3.51
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Revenue (Annual): 18.14M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.14M |
| December 31, 2022 | 39.02M |
| December 31, 2021 | 10.99M |
| December 31, 2020 | 6.914M |
| December 31, 2019 | 6.011M |
| December 31, 2018 | 5.945M |
| December 31, 2017 | 10.70M |
| December 31, 2016 | 1.491M |
| December 31, 2015 | 23.28M |
| December 31, 2014 | 14.95M |
| December 31, 2013 | 15.46M |
| December 31, 2012 | 14.10M |
| December 31, 2011 | 16.81M |
| Date | Value |
|---|---|
| December 31, 2010 | 21.35M |
| December 31, 2009 | 13.78M |
| December 31, 2008 | 9.640M |
| December 31, 2007 | 15.92M |
| December 31, 2006 | 13.60M |
| December 31, 2005 | 13.29M |
| December 31, 2004 | 12.17M |
| December 31, 2003 | 2.732M |
| December 31, 2002 | 5.082M |
| December 31, 2001 | 3.114M |
| December 31, 2000 | 0.0483M |
| December 31, 1999 | 1.140M |
| December 31, 1998 | 1.227M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
6.011M
Minimum
2019
39.02M
Maximum
2022
16.21M
Average
10.99M
Median
2021
Revenue (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 2.419B |
| Amicus Therapeutics Inc | 399.36M |
| Ionis Pharmaceuticals Inc | 787.65M |
| GlycoMimetics Inc | 0.01M |
| FibroGen Inc | 147.75M |